![Jeanette Wood](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeanette Wood
Président chez
RocketVax AG
Profil
Jeanette Wood is currently the Chairman at RocketVax AG since 2020.
She previously worked as an Independent Director at Nuevolution AB. From 2014 to 2016, she was the Chief Scientific Officer at Calliditas Therapeutics Suisse SA. She also worked as a Senior Manager at Novartis AG and Ciba-Geigy AG from 1980 to 2006.
From 2012 to 2014, she was the Vice President & Head-Science at AstraZeneca UK Ltd. She was the Head-Biology at S*BIO Pte Ltd. from 2006 to 2011.
Dr. Wood holds a doctorate degree from the University of Otago.
Postes actifs de Jeanette Wood
| Sociétés | Poste | Début |
|---|---|---|
RocketVax AG
 RocketVax AG BiotechnologyHealth Technology Engages in development of vaccines | Président | 01/11/2020 |
Anciens postes connus de Jeanette Wood
| Sociétés | Poste | Fin |
|---|---|---|
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Directeur Technique/Scientifique/R&D | 01/01/2016 |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2014 |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers novel targeted small molecule drugs | Corporate Officer/Principal | 01/01/2011 |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01/01/2006 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2006 |
Formation de Jeanette Wood
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Otago
 University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Commercial Services |
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases | Health Technology |
S*BIO Pte Ltd.
S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers novel targeted small molecule drugs | Health Technology |
RocketVax AG
RocketVax AG BiotechnologyHealth Technology Engages in development of vaccines | Health Technology |
